Bioequivalence Waivers: When the FDA Allows Generic Drugs Without Human Trials
The FDA allows bioequivalence waivers for certain generic drugs, skipping human trials when in vitro dissolution tests prove the product behaves the same as the brand. Learn how BCS classification and dissolution profiles make this possible.
Read More